ChloroquineV1, Main, Exploration, bibRecord, 001F62

Reactivation of Latent Epstein–Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas

Identifieur interne : 001F62 ( Main/Exploration ); précédent : 001F61; suivant : 001F63

Reactivation of Latent Epstein–Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas

Auteurs : Wen-Hai Feng [États-Unis] ; Jeffrey I. Cohen [États-Unis] ; Steven Fischer [États-Unis] ; Li Li [États-Unis] ; Michael Sneller [États-Unis] ; Raphael Goldbach-Mansky [États-Unis] ; Nancy Raab-Traub [États-Unis] ; Henri-Jacques Delecluse [États-Unis] ; Shannon C. Kenney [États-Unis]

Source :

Journal of the National Cancer Institute [ 0027-8874 ] ; 2004.

RBID : ISTEX:57147FC45F2F730EF2CB66C03DF266B94A29EE85

Abstract

Background: Patients with rheumatoid arthritis or polymyositis treated with methotrexate (MTX) develop Epstein–Barr virus (EBV)–positive lymphomas more frequently than patients treated with other, equally immunosuppressive regimens. Here we determined whether MTX, in contrast to other commonly used medications for rheumatoid arthritis or polymyositis, is unique in its ability to induce the release of infectious EBV from latently infected cells. Methods: The effect of MTX and other immunosuppressant drugs on EBV replication in vitro was assessed using latently infected EBV-positive lymphoblastoid and gastric carcinoma cell lines. Inhibitors of signal transduction pathways were used to define requirements for induction of lytic infection. Drug effects on transcription of the two EBV immediate-early promoters (BRLF1 and BZLF1) and on promoter constructs lacking cis-acting sequences required for activation by other effectors was examined using reporter gene assays. EBV viral load in rheumatoid arthritis and polymyositis patients receiving MTX was compared with that in patients receiving other immunosuppressive medications. Statistical tests were two-sided. Results: MTX activated the release of infectious EBV from latently infected cell lines in vitro, and MTX treatment was associated with activation of the two viral immediate-early promoters in reporter gene assays. Induction of lytic EBV infection by MTX required the p38 MAP kinase, PI3 kinase, and MEK pathways and specific cis-acting motifs in the two viral immediate-early promoters. Patients treated with MTX-containing regimens had statistically significantly higher mean EBV loads in their blood than patients treated with immunosuppressing regimens that did not include MTX (40 EBV copies per 106 cellular genomes versus 5.1 copies; geometric mean fold difference in copies = 10.8, 95%, confidence interval = 3.0 to 38; P = .011). Conclusion: MTX may promote EBV-positive lymphomas in rheumatoid arthritis and polymyositis patients by its immunosuppressive properties as well as by reactivating latent EBV.

Url:

https://api.istex.fr/ark:/67375/HXZ-69VRWDTJ-V/fulltext.pdf

DOI: 10.1093/jnci/djh313

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: 001953
to stream Istex, to step Curation: 001953
to stream Istex, to step Checkpoint: 000E03
to stream Main, to step Merge: 001F77
to stream Main, to step Curation: 001F62

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reactivation of Latent Epstein–Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas</title>
<author><name sortKey="Feng, Wen Hai" sort="Feng, Wen Hai" uniqKey="Feng W" first="Wen-Hai" last="Feng">Wen-Hai Feng</name>
</author>
<author><name sortKey="Cohen, Jeffrey I" sort="Cohen, Jeffrey I" uniqKey="Cohen J" first="Jeffrey I." last="Cohen">Jeffrey I. Cohen</name>
</author>
<author><name sortKey="Fischer, Steven" sort="Fischer, Steven" uniqKey="Fischer S" first="Steven" last="Fischer">Steven Fischer</name>
</author>
<author><name sortKey="Li, Li" sort="Li, Li" uniqKey="Li L" first="Li" last="Li">Li Li</name>
</author>
<author><name sortKey="Sneller, Michael" sort="Sneller, Michael" uniqKey="Sneller M" first="Michael" last="Sneller">Michael Sneller</name>
</author>
<author><name sortKey="Goldbach Mansky, Raphael" sort="Goldbach Mansky, Raphael" uniqKey="Goldbach Mansky R" first="Raphael" last="Goldbach-Mansky">Raphael Goldbach-Mansky</name>
</author>
<author><name sortKey="Raab Traub, Nancy" sort="Raab Traub, Nancy" uniqKey="Raab Traub N" first="Nancy" last="Raab-Traub">Nancy Raab-Traub</name>
</author>
<author><name sortKey="Delecluse, Henri Jacques" sort="Delecluse, Henri Jacques" uniqKey="Delecluse H" first="Henri-Jacques" last="Delecluse">Henri-Jacques Delecluse</name>
</author>
<author><name sortKey="Kenney, Shannon C" sort="Kenney, Shannon C" uniqKey="Kenney S" first="Shannon C." last="Kenney">Shannon C. Kenney</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:57147FC45F2F730EF2CB66C03DF266B94A29EE85</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1093/jnci/djh313</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-69VRWDTJ-V/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001953</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001953</idno>
<idno type="wicri:Area/Istex/Curation">001953</idno>
<idno type="wicri:Area/Istex/Checkpoint">000E03</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000E03</idno>
<idno type="wicri:doubleKey">0027-8874:2004:Feng W:reactivation:of:latent</idno>
<idno type="wicri:Area/Main/Merge">001F77</idno>
<idno type="wicri:Area/Main/Curation">001F62</idno>
<idno type="wicri:Area/Main/Exploration">001F62</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Reactivation of Latent Epstein–Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas</title>
<author><name sortKey="Feng, Wen Hai" sort="Feng, Wen Hai" uniqKey="Feng W" first="Wen-Hai" last="Feng">Wen-Hai Feng</name>
<affiliation wicri:level="4"><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
<country>États-Unis</country>
<placeName><settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cohen, Jeffrey I" sort="Cohen, Jeffrey I" uniqKey="Cohen J" first="Jeffrey I." last="Cohen">Jeffrey I. Cohen</name>
<affiliation wicri:level="4"><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
<country>États-Unis</country>
<placeName><settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fischer, Steven" sort="Fischer, Steven" uniqKey="Fischer S" first="Steven" last="Fischer">Steven Fischer</name>
<affiliation wicri:level="4"><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
<country>États-Unis</country>
<placeName><settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Li, Li" sort="Li, Li" uniqKey="Li L" first="Li" last="Li">Li Li</name>
<affiliation wicri:level="4"><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
<country>États-Unis</country>
<placeName><settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sneller, Michael" sort="Sneller, Michael" uniqKey="Sneller M" first="Michael" last="Sneller">Michael Sneller</name>
<affiliation wicri:level="4"><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
<country>États-Unis</country>
<placeName><settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Goldbach Mansky, Raphael" sort="Goldbach Mansky, Raphael" uniqKey="Goldbach Mansky R" first="Raphael" last="Goldbach-Mansky">Raphael Goldbach-Mansky</name>
<affiliation wicri:level="4"><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
<country>États-Unis</country>
<placeName><settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Raab Traub, Nancy" sort="Raab Traub, Nancy" uniqKey="Raab Traub N" first="Nancy" last="Raab-Traub">Nancy Raab-Traub</name>
<affiliation wicri:level="4"><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
<country>États-Unis</country>
<placeName><settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Delecluse, Henri Jacques" sort="Delecluse, Henri Jacques" uniqKey="Delecluse H" first="Henri-Jacques" last="Delecluse">Henri-Jacques Delecluse</name>
<affiliation wicri:level="4"><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
<country>États-Unis</country>
<placeName><settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kenney, Shannon C" sort="Kenney, Shannon C" uniqKey="Kenney S" first="Shannon C." last="Kenney">Shannon C. Kenney</name>
<affiliation wicri:level="4"><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
<country>États-Unis</country>
<placeName><settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of the National Cancer Institute</title>
<title level="j" type="abbrev">JNCI J Natl Cancer Inst</title>
<idno type="ISSN">0027-8874</idno>
<idno type="eISSN">1460-2105</idno>
<imprint><publisher>Oxford University Press</publisher>
<date when="2004-11-17">2004</date>
<biblScope unit="vol">96</biblScope>
<biblScope unit="issue">22</biblScope>
<biblScope unit="page" from="1691">1691</biblScope>
<biblScope unit="page" to="1702">1702</biblScope>
</imprint>
<idno type="ISSN">0027-8874</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0027-8874</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: Patients with rheumatoid arthritis or polymyositis treated with methotrexate (MTX) develop Epstein–Barr virus (EBV)–positive lymphomas more frequently than patients treated with other, equally immunosuppressive regimens. Here we determined whether MTX, in contrast to other commonly used medications for rheumatoid arthritis or polymyositis, is unique in its ability to induce the release of infectious EBV from latently infected cells. Methods: The effect of MTX and other immunosuppressant drugs on EBV replication in vitro was assessed using latently infected EBV-positive lymphoblastoid and gastric carcinoma cell lines. Inhibitors of signal transduction pathways were used to define requirements for induction of lytic infection. Drug effects on transcription of the two EBV immediate-early promoters (BRLF1 and BZLF1) and on promoter constructs lacking cis-acting sequences required for activation by other effectors was examined using reporter gene assays. EBV viral load in rheumatoid arthritis and polymyositis patients receiving MTX was compared with that in patients receiving other immunosuppressive medications. Statistical tests were two-sided. Results: MTX activated the release of infectious EBV from latently infected cell lines in vitro, and MTX treatment was associated with activation of the two viral immediate-early promoters in reporter gene assays. Induction of lytic EBV infection by MTX required the p38 MAP kinase, PI3 kinase, and MEK pathways and specific cis-acting motifs in the two viral immediate-early promoters. Patients treated with MTX-containing regimens had statistically significantly higher mean EBV loads in their blood than patients treated with immunosuppressing regimens that did not include MTX (40 EBV copies per 106 cellular genomes versus 5.1 copies; geometric mean fold difference in copies = 10.8, 95%, confidence interval = 3.0 to 38; P = .011). Conclusion: MTX may promote EBV-positive lymphomas in rheumatoid arthritis and polymyositis patients by its immunosuppressive properties as well as by reactivating latent EBV.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Caroline du Nord</li>
</region>
<settlement><li>Chapel Hill (Caroline du Nord)</li>
</settlement>
<orgName><li>Université de Caroline du Nord à Chapel Hill</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Caroline du Nord"><name sortKey="Feng, Wen Hai" sort="Feng, Wen Hai" uniqKey="Feng W" first="Wen-Hai" last="Feng">Wen-Hai Feng</name>
</region>
<name sortKey="Cohen, Jeffrey I" sort="Cohen, Jeffrey I" uniqKey="Cohen J" first="Jeffrey I." last="Cohen">Jeffrey I. Cohen</name>
<name sortKey="Delecluse, Henri Jacques" sort="Delecluse, Henri Jacques" uniqKey="Delecluse H" first="Henri-Jacques" last="Delecluse">Henri-Jacques Delecluse</name>
<name sortKey="Fischer, Steven" sort="Fischer, Steven" uniqKey="Fischer S" first="Steven" last="Fischer">Steven Fischer</name>
<name sortKey="Goldbach Mansky, Raphael" sort="Goldbach Mansky, Raphael" uniqKey="Goldbach Mansky R" first="Raphael" last="Goldbach-Mansky">Raphael Goldbach-Mansky</name>
<name sortKey="Kenney, Shannon C" sort="Kenney, Shannon C" uniqKey="Kenney S" first="Shannon C." last="Kenney">Shannon C. Kenney</name>
<name sortKey="Li, Li" sort="Li, Li" uniqKey="Li L" first="Li" last="Li">Li Li</name>
<name sortKey="Raab Traub, Nancy" sort="Raab Traub, Nancy" uniqKey="Raab Traub N" first="Nancy" last="Raab-Traub">Nancy Raab-Traub</name>
<name sortKey="Sneller, Michael" sort="Sneller, Michael" uniqKey="Sneller M" first="Michael" last="Sneller">Michael Sneller</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F62 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001F62 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:57147FC45F2F730EF2CB66C03DF266B94A29EE85
   |texte=   Reactivation of Latent Epstein–Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas
}}

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Chloroquine

Reactivation of Latent Epstein–Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas

Reactivation of Latent Epstein–Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri